ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
SW3E524
|
1.0K |
389K |
6 |
05/08/23 |
05/08/23 |
ASX - By Stock
|
1.0K
|
389K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
SW3E524
|
1.3K |
544K |
2 |
02/08/23 |
02/08/23 |
ASX - By Stock
|
1.3K
|
544K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
SW3E524
|
5.0K |
2.4M |
3 |
01/08/23 |
01/08/23 |
ASX - By Stock
|
5.0K
|
2.4M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
SW3E524
|
17K |
6.6M |
3 |
27/11/22 |
27/11/22 |
ASX - By Stock
|
17K
|
6.6M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Voluntary Suspension
|
|
SW3E524
|
332 |
117K |
23 |
08/08/22 |
08/08/22 |
ASX - By Stock
|
332
|
117K
|
23
|
|
ASX - By Stock
|
ZIP |
Re:
what happens to shorters if it goes to zero?
|
|
SW3E524
|
4 |
1.6K |
1 |
07/06/22 |
07/06/22 |
ASX - By Stock
|
4
|
1.6K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Things that never get said to SI.......
|
|
SW3E524
|
49 |
16K |
1 |
10/03/22 |
10/03/22 |
ASX - By Stock
|
49
|
16K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
CHF Accelerated Approval !
|
|
SW3E524
|
144 |
56K |
17 |
10/03/22 |
10/03/22 |
ASX - By Stock
|
144
|
56K
|
17
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on Novartis Agreement
|
|
SW3E524
|
850 |
249K |
4 |
16/12/21 |
16/12/21 |
ASX - By Stock
|
850
|
249K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Pause in Trading
|
|
SW3E524
|
115 |
45K |
1 |
14/12/21 |
14/12/21 |
ASX - By Stock
|
115
|
45K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
SW3E524
|
5.0K |
2.4M |
5 |
08/12/21 |
08/12/21 |
ASX - By Stock
|
5.0K
|
2.4M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Chairman Message to 2021 AGM
|
|
SW3E524
|
54 |
20K |
7 |
29/11/21 |
29/11/21 |
ASX - By Stock
|
54
|
20K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Chairman Message to 2021 AGM
|
|
SW3E524
|
54 |
20K |
7 |
29/11/21 |
29/11/21 |
ASX - By Stock
|
54
|
20K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Chairman Message to 2021 AGM
|
|
SW3E524
|
54 |
20K |
13 |
29/11/21 |
29/11/21 |
ASX - By Stock
|
54
|
20K
|
13
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
SW3E524
|
10K |
3.0M |
3 |
26/11/21 |
26/11/21 |
ASX - By Stock
|
10K
|
3.0M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Whats the meaning of the closing remark by SI today?
|
|
SW3E524
|
25 |
8.6K |
2 |
24/11/21 |
24/11/21 |
ASX - By Stock
|
25
|
8.6K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Growing doubt on COVID-19 Application
|
|
SW3E524
|
4.7K |
1.0M |
12 |
24/11/21 |
24/11/21 |
ASX - By Stock
|
4.7K
|
1.0M
|
12
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
SW3E524
|
5.0K |
2.4M |
12 |
20/11/21 |
20/11/21 |
ASX - By Stock
|
5.0K
|
2.4M
|
12
|
|
ASX - By Stock
|
MSB |
Re:
1st Quarter Results Release
|
|
SW3E524
|
6 |
2.1K |
12 |
18/11/21 |
18/11/21 |
ASX - By Stock
|
6
|
2.1K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
1st Quarter Results Release
|
|
SW3E524
|
6 |
2.1K |
5 |
18/11/21 |
18/11/21 |
ASX - By Stock
|
6
|
2.1K
|
5
|
|
Charts
|
MSB |
Re:
MSB Charts
|
|
SW3E524
|
888 |
641K |
10 |
15/11/21 |
15/11/21 |
Charts
|
888
|
641K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Ann: CHF Late Breaker Presentation at American Heart Association
|
|
SW3E524
|
350 |
124K |
7 |
15/11/21 |
15/11/21 |
ASX - By Stock
|
350
|
124K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Novartis Exiting Roche - Cas$$$ed Up
|
|
SW3E524
|
128 |
39K |
8 |
05/11/21 |
05/11/21 |
ASX - By Stock
|
128
|
39K
|
8
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
SW3E524
|
10K |
3.0M |
1 |
04/11/21 |
04/11/21 |
ASX - By Stock
|
10K
|
3.0M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
15 Days until doubt is removed
|
|
SW3E524
|
953 |
288K |
9 |
03/11/21 |
03/11/21 |
ASX - By Stock
|
953
|
288K
|
9
|
|
ASX - By Stock
|
ZIP |
Re:
Modereted
|
|
SW3E524
|
17 |
3.7K |
1 |
02/11/21 |
02/11/21 |
ASX - By Stock
|
17
|
3.7K
|
1
|
|
ASX - By Stock
|
ZIP |
Re:
Short of 2022?
|
|
SW3E524
|
103 |
28K |
1 |
02/11/21 |
02/11/21 |
ASX - By Stock
|
103
|
28K
|
1
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
SW3E524
|
10K |
3.0M |
15 |
29/10/21 |
29/10/21 |
ASX - By Stock
|
10K
|
3.0M
|
15
|
|
ASX - By Stock
|
NZS |
Re:
Ann: Quarterly Update and Appendix 4C
|
|
SW3E524
|
43 |
26K |
18 |
29/10/21 |
29/10/21 |
ASX - By Stock
|
43
|
26K
|
18
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
SW3E524
|
10K |
3.0M |
3 |
28/10/21 |
28/10/21 |
ASX - By Stock
|
10K
|
3.0M
|
3
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
SW3E524
|
10K |
3.0M |
6 |
27/10/21 |
27/10/21 |
ASX - By Stock
|
10K
|
3.0M
|
6
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
SW3E524
|
10K |
3.0M |
8 |
27/10/21 |
27/10/21 |
ASX - By Stock
|
10K
|
3.0M
|
8
|
|
ASX - By Stock
|
SGR |
Re:
News: SGR Star Entertainment Group Updates On Regular Review Of The Star Sydney
|
|
SW3E524
|
34 |
9.2K |
3 |
26/10/21 |
26/10/21 |
ASX - By Stock
|
34
|
9.2K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Where is Novartis?
|
|
SW3E524
|
1.5K |
411K |
114 |
23/10/21 |
23/10/21 |
ASX - By Stock
|
1.5K
|
411K
|
114
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
SW3E524
|
5.0K |
2.4M |
2 |
23/10/21 |
23/10/21 |
ASX - By Stock
|
5.0K
|
2.4M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
SW3E524
|
5.0K |
2.4M |
6 |
20/10/21 |
20/10/21 |
ASX - By Stock
|
5.0K
|
2.4M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
SW3E524
|
17K |
6.6M |
9 |
15/10/21 |
15/10/21 |
ASX - By Stock
|
17K
|
6.6M
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
SW3E524
|
17K |
6.6M |
10 |
15/10/21 |
15/10/21 |
ASX - By Stock
|
17K
|
6.6M
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Anniversary day share price predictions
|
|
SW3E524
|
34 |
10K |
6 |
06/10/21 |
06/10/21 |
ASX - By Stock
|
34
|
10K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
SW3E524
|
17K |
6.6M |
4 |
05/10/21 |
05/10/21 |
ASX - By Stock
|
17K
|
6.6M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Moderated
|
|
SW3E524
|
1.5K |
498K |
23 |
01/10/21 |
01/10/21 |
ASX - By Stock
|
1.5K
|
498K
|
23
|
|
ASX - By Stock
|
ZIP |
Re:
Ann: Zip makes strategic move into India
|
|
SW3E524
|
283 |
90K |
15 |
22/09/21 |
22/09/21 |
ASX - By Stock
|
283
|
90K
|
15
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
SW3E524
|
10K |
3.0M |
7 |
22/09/21 |
22/09/21 |
ASX - By Stock
|
10K
|
3.0M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Rem-L for the Ages
|
|
SW3E524
|
1 |
873 |
8 |
17/09/21 |
17/09/21 |
ASX - By Stock
|
1
|
873
|
8
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
SW3E524
|
10K |
3.0M |
7 |
14/09/21 |
14/09/21 |
ASX - By Stock
|
10K
|
3.0M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 3G and 3H
|
|
SW3E524
|
41 |
12K |
13 |
30/08/21 |
30/08/21 |
ASX - By Stock
|
41
|
12K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
SW3E524
|
17K |
6.6M |
7 |
27/08/21 |
27/08/21 |
ASX - By Stock
|
17K
|
6.6M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Why i bought today
|
|
SW3E524
|
212 |
47K |
8 |
27/08/21 |
27/08/21 |
ASX - By Stock
|
212
|
47K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
SW3E524
|
17K |
6.6M |
0 |
26/08/21 |
26/08/21 |
ASX - By Stock
|
17K
|
6.6M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
MSB website indicates Novartis agreement as conditions met.
|
|
SW3E524
|
158 |
46K |
2 |
21/08/21 |
21/08/21 |
ASX - By Stock
|
158
|
46K
|
2
|
|